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Abstract
Background: A considerable percentage of multiple sclerosis patients have attentional impairment, but understanding its
neurophysiological basis remains a challenge. The Attention Network Test allows 3 attentional networks to be studied.
Previous behavioural studies using this test have shown that the alerting network is impaired in multiple sclerosis. The aim
of this study was to identify neurophysiological indexes of the attention impairment in relapsing-remitting multiple sclerosis
patients using this test.
Results: After general slowing had been removed in patients group to isolate the effects of each condition, some behavioral
differences between them were obtained. About Contingent Negative Variation, a statistically significant decrement were
found in the amplitude for Central and Spatial Cue Conditions for patient group (p,0.05). ANOVAs showed for the patient
group a significant latency delay for P1 and N1 components (p,0.05) and a decrease of P3 amplitude for congruent and
incongruent stimuli (p,0.01). With regard to correlation analysis, PASAT-3s and SDMT showed significant correlations with
behavioral measures of the Attention Network Test (p,0.01) and an ERP parameter (CNV amplitude).
Conclusions: Behavioral data are highly correlated with the neuropsychological scores and show that the alerting and
orienting mechanisms in the patient group were impaired. Reduced amplitude for the Contingent Negative Variation in the
patient group suggests that this component could be a physiological marker related to the alerting and orienting
impairment in relapsing-remitting multiple sclerosis. P1 and N1 delayed latencies are evidence of the demyelination process
that causes impairment in the first steps of the visual sensory processing. Lastly, P3 amplitude shows a general decrease for
the pathological group probably indexing a more central impairment. These results suggest that the Attention Network Test
give evidence of multiple levels of attention impairment, which could help in the assessment and treatment of relapsing-
remitting multiple sclerosis patients.
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Introduction
Cognitive impairment is evident in up to 70% of patients with
confirmed multiple sclerosis (MS) [1]. The most frequently
impaired cognitive domains in MS patients are processing speed,
memory and attention [2,3,4]. To understand the neural basis of
the cognitive impairment in this pathology several techniques have
been used [5,6,7]. Cognitive potentials have been measured
during the performance of a particular task to correlate behavior
and physiology [8,9,10,11,12].
A few years ago, a particular task, the Attention Network Test
(ANT), was developed by Fan et al [13]. It permits 3 attentional
networks to be studied in a brief experimental session. These
networks - alerting, orienting and executive - have been proposed
on the basis of many studies, and their anatomical and
physiological properties have been defined [14].
The attentional mechanisms studied by ANT are as follows
[13,14]. First, a general preparatory state or the "arousal" level
needed for rapid detection of expected stimulus is managed by the
alerting network, and is associated with increased activity in the
right frontal lobe and right parietal lobe. These regions receive
noradrenergic projections (related to alertness) from the locus
coeruleus. Second, the movement of the attentional focus is
allowed by the orienting network. The brain areas involved are the
posterior parietal cortex, the thalamic pulvinar nucleus, the
superior colliculus and the frontal eye fields. The orienting
network is associated with the cholinergic system. Last, the
executive network is responsible for conflict resolution (stimulus or
response), error detection and inhibitory control, which is
associated with the activity of the Anterior Cingular Cortex
(ACC) and the lateral prefrontal cortex. These regions contain a
large number of dopamine receptors, suggesting that the
dopamine system is involved in the executive network.
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Although these attentional networks have a certain degree of
independence between them [13,14,15], other studies have
demonstrated that interaction exists between networks. For
instance, some ANT studies on healthy subjects show an
interdependence between the alerting and executive systems
[16,17].
Some studies combining ANT design and Event-Related
Potentials (ERPs) have tried to clarify the neural correlates of
attentional mechanisms involved in this test. Neuhaus et al. [18]
looking at the modulations of N1 in the ANT found that the
amplitude was modulated by the alerting and orienting networks.
In particular, low amplitude was present for the no cue condition,
bigger for the double cue condition, and highest for the spatial cue
condition. They also analyzed the effect on the P3 component
caused by the congruence variable, showing that the congruent
stimuli had higher amplitude than the incongruent stimuli. They
indicated that the difference could be related to response
inhibition, although the contribution of the difficulty of the task
cannot be ruled out. In children, with ADHD and a healthy
control group were analyzed by Kratz et al. [19] for potential
modulations in the Contingent Negative Variation (CNV) interval.
They found an increase of the amplitude in the late phase of the
CNV for the spatial cue condition with respect to the neutral cue
condition in healthy controls. However, no analyses were for the
no cue condition or the central cue condition. Missonnier et al.
[20], in analyzing all the conditions, concluded that the CNV
amplitude was related with the amount of information given for
the cue. The CNV amplitude was larger for the more informative
spatial cue (alerting and orienting, temporally and spatially
informative) compared to the less informative central cue (alerting,
temporally informative), and obviously in the absence of a cue. In
line with this evidence, only one study has investigated the
functional significance of CNV in different clinical forms of MS
patients, using, however, a Posner cuing task. Gonzalez-Rosa et al.
[9] found a reduction in amplitude in the initial phase of the CNV
in their MS patients. This ‘‘early’’ CNV has usually been related to
sensory processes associated with evaluating the information
contained in the warning, and is functionally interpreted in terms
of activation of an executive mechanism controlling orientation or
attention to a stimulus [21,22,23]. This reduction of amplitude
suggests a reduced or worse activation of orientation and
preparation mechanisms in some MS patients following the
presentation of a cue [9].
Using ANT and behavioral measures in MS patients, only 3
studies have demonstrated an impairment of the alerting network,
but no effect on the orienting network [24,25,26]. Only one study
has tried to identify the possible neural correlates related with the
behavioral impairment in MS applying the ANT [24], however
only structural MRI parameters were analyzed and no functional
measurements were made.
Thus, this is the first study analyzing the ERP indexes
(functional measures) and attentional deficits in a group of MS
patients performing the ANT. Specifically, the study of the
neurophysiological correlates in this test will allow the evaluation
of the functioning of the three attentional networks and the
alterations in patients with relapsing-remitting multiple sclerosis
(RRMS). A better knowledge of the attentional impairment in this
pathology and its neurophysiological basis could improve our
capacity to assess and refine therapeutic strategies.
Predictions
Considering that MS can cause a demyelination process and
neuronal death, highly distributed attentional mechanisms can be
impaired (alerting and orienting) and some neural correlates can
be identified using ERP analysis [8,9,10,11,12]. In particular, we
believe a reduction of the CNV amplitude can be expected for the
patients group that reflects the impairment in alerting and
orienting mechanism engaged by the cue. Moreover, a delay in
the latency for early ERP components (P1 and N1) triggered by
the target stimuli and a decrement for the amplitude in the P3
component related to impairment in more central cognitive
processes are also expected. Finally, neuropsychological scores will
probably show some degree of correlation with psychophysiolog-




This study was carried out in compliance with the Helsinki
Declaration. All participants signed informed consents before their
inclusion and the protocol was approved by the ethics committee
of the University of Seville (project code: PSI2010-16825).
Patient Population and Study participants
Twenty-six patients with a definite diagnosis of relapsing-
remitting multiple sclerosis (RRMS) according to the Poser criteria
[29] were consecutively recruited in our MS Unit. The Expanded
Disability Status Scale (EDSS) [30] was used in all the patients and
the duration of disease in years was registered. Exclusion criteria
included: forms of MS other than RRMS; ,30 days free of clinical
relapses; EDSS score over 6; presence of comorbid neurodegen-
erative or psychiatric disorders; history of alcohol or drug abuse;
head trauma; vascular diseases and seizures; severe signs of
depression; significant upper limb impairment; or visual acuity or
field deficits. An equal number of healthy subjects were recruited
for the study. Independent t-test and Chi-Square test were used to
compare socio-demographic variables between groups.
Neuropsychological Assessment
Before the ERP study, neuropsychological testing and depres-
sion assessment of the patients were given to well-trained
psychologists blinded to the study goals. Cognitive functioning
(attention, concentration and speed of information processing) was
measured through the Paced Auditory Serial Addition Test, 3
seconds (PASAT-3s) [31,32] and the Symbol Digit Modality Test
(SDMT) [33,34] and compared to the normative scores developed
by Sepulcre et al. [35] Beck Depression Inventory (BDI-II) [36,37]
was used to assess symptoms of depression.
Cognitive Task
The Attention Network Test (ANT) was used as per the original
authors [13]. Stimuli consisted of a row of 5 horizontal white lines,
with arrowheads pointing left or right, against a black background
(see figure 1). There were 2 types of target stimuli: a congruent
target (C), when the central arrow was flanked by other arrows
pointing in the same direction, and an incongruent target (I), when
the flanking arrows pointed in opposite directions. Target stimuli
represented a total visual angle of 3.28 on the x axis and 0.41 on
the y axis. The congruent and incongruent trials occurred in equal
proportions. Under each condition (congruent or incongruent),
half were pointing to the left and half to the right. The subjects task
was to indicate the direction of the central arrow by pressing the
left button/arrow pointing to the left with the left thumb, or the
right button/arrow pointing to the right with the right thumb.
The target was presented in one of two locations, either 0.86u
above or below the fixation cross in the center of the display, the
cross appearing in the center of the visual display throughout the
Cognitive Impairment in Multiple Sclerosis
PLOS ONE | www.plosone.org 2 May 2014 | Volume 9 | Issue 5 | e97226
entire experiment. To engage the alerting and orienting processes,
a cue (an asterisk symbol) was shown before the appearance of
target. There were 3 cue conditions: no cue (NC), central cue (at
the fixation cross for alerting; CC), and spatial cue (at the target
location for alerting plus orienting; SC). All cues occurred in the
same proportions. Cues were displayed with a visual angle of 0.41o
on the x axis and 0.41o on the y axis. In the NC condition, a black
square the same size as the cue was shown (not visible to the
subjects) to adapt all the timings for the different cue conditions
and make them comparable for ERP analysis. As a result of the
combination of target and cue conditions, the following 6
conditions were applied: No Cue Congruent (NC-C), No Cue
Incongruent (NC-I); Central Cue Congruent (CC-C); Central Cue
Incongruent (CC-I); Spatial Cue Congruent (SC-C) and Spatial
Cue Incongruent (SC-I).
Some adaptations in the experimental procedure were made for
our clinical group (see figure 1). The duration of the cue was
150ms before a fixed duration of 1,000ms. The target (with
flankers) was then presented for 350ms. The time-window for
participants’ response was 1,000 ms after target onset and the
duration between the offset of the target and the start of the next
trial was variable (1,000ms; 1,500ms or 2,000ms).
The experiment consisted of 288 trials in 2 blocks of 144. All the
trials (diverse cues and different possible targets) were randomly
presented in both blocks. With respect to behavior analysis, as
suggested by others [16,17], we analyzed the interactions between
conditions, but without subtractions (network effects) that could
hide specific attentional mechanisms. Therefore, reaction time and
accuracy were calculated for all conditions and averaged
separately. Trials with an error were not included in the
behavioral or ERP analysis. All the participants were instructed
to respond as quickly and accurately as possible.
EEG procedure
The electroencephalogram (EEG) was recorded from 58 scalp
electrodes (Fp1, Fpz, Fp2, F3A, F4A, F7, F5, F3, F1, Fz, F2, F4,
F6, F8, FC5, FC3, FC1, FCz, FC2, FC4, FC6, T3, C5, C3, C1,
Cz, C2, C4, C6, T4, T3L, CP5, CP3, CP1, CPz, CP2, CP4, CP6,
T4L, T5, P5, P3, P1, Pz, P2, P4, P6, T6, PO5, PO3, PO1, POz,
PO2, PO4, PO6, O1, Oz, O2) (see figure 2), all of which were
compared to an averaged reference. Vertical and horizontal
electro-oculograms (VEOG and HEOG) were recorded. The
electrode signals were amplified with BrainAmp amplifiers and
digitally stored using Brain Vision Recorder software (Brain
Products GmbH, Germany). The EEG signal was digitized at
500 Hz and filtered through the amplifier using a band-pass of
0.01–100 Hz, with the impedance below 5 kOhm during the
experiment. Trials with a HEOG signal outside the 675 mV range
were rejected. To obtain a good and balanced signal-to-noise ratio
between conditions, all the individual averages also comprised .
45 artifact-free trials [38,39].
CNV amplitude was analyzed for each cue condition in the
time-window of 400 ms prior to the arrival of the target stimulus.
As suggested by Duncan et al. (2009) [38], the latency and
amplitude for P1 and N1 components were measured as follows:
finding the electrode with the maximum amplitude, identifying the
latency of this peak and then exporting the amplitude value at that
latency for the rest of derivations included in the analysis. In the
case of the P3 component, Pz electrode showed the maximum
amplitude and had two peaks in some cases that were not
recognizable in all subjects for latency analysis. Therefore, only
amplitude analysis based in a range defined in the grand average
(300–700 ms) was set for this component in both target conditions
(congruent and incongruent). Derivations used to analyze latencies
and/or amplitudes for all these components are depicted in
figure 2.
Statistical analysis
For behavioral analysis (reaction time and accuracy), a Mixed
Repeated Measures ANOVA (MR-ANOVA) was used with the
following factors and levels: Cue (No cue, Central cue and Spatial
cue) x Congruence (Congruent and Incongruent) x Group
(Patients and Controls). General slowing was analyzed as the
result of the main factor ‘‘Group’’. After this calculation, the
Reaction Time (RT) data were corrected following the recom-
mendation by Fernández-Duque and Black [40] to exclude
differences between groups under all conditions caused by general
slowing, and then an identical MR-ANOVA was used with the
corrected data. The effects over specific experimental conditions
could then be analyzed.
Figure 1. Experimental procedure. The possible combinations for sets of cues and targets were six: No cue congruent (NC-C), No cue incongruent
(NC-I), Central cue congruent (CC-C), Central cue incongruent (CC-I), Spatial cue congruent (SC-C) and Spatial cue incongruent (SC-I).
doi:10.1371/journal.pone.0097226.g001
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To analyze independently alerting and orienting attentional
networks, CNV amplitude was analyzed by 3 MR-ANOVAs (one
for each cuing condition) with the following factors (levels):
Anteroposterior location factor (Frontal, Frontocentral, Central
and Centro-parietal); Medial-lateral Position factor (Left, Central
and Right location); and Group factor (Patients and Controls) (see
figure 2).
To evaluate the interaction between attentional networks in the
amplitude of P1 and N1 components between groups, 2 MR-
ANOVAs were used (one for each component analyzed) with a
362626662 design: Cue factor (no cue, central cue and spatial
cue), Congruence factor (congruent and incongruent), Anteropos-
terior location factor (Parietal and Parieto-occipital), Medial-
Lateral Position factor (Line 5, Line 3, Line 1 (for the left
hemisphere) and Line 2, Line 4, Line 6 (for the right hemisphere)
and Group factor (Patients and Controls) (see figure 2).
P1 and N1 latency was analyzed using an MR-ANOVA for
each component with a 36262 design: Cue factor (no cue, central
cue and spatial cue), Congruence factor (congruent and incon-
gruent) and Group factor (Patients and Controls).
Amplitude modulations of the P3 component were analyzed
with an MR-ANOVA with the following factors: Congruence
factor (congruent and incongruent), Anteroposterior location
factor (Central, Centro-parietal, Parietal and Parieto-occipital),
Medial-Lateral Position factor (Left, Central and Right location)
and Group factor (Patients and Controls) (see figure 2).
All variables were checked for normality using the Shapiro-Wilk
test (p.0.05). A Greenhouse-Geisser correction for sphericity was
applied and p # 0.05 was considered significant. The Bonferroni
correction was used in multiple comparisons post-hoc analysis.
A Spearman rank test was used to estimate the correlation
between clinical data (i.e., EDSS, duration of the disease in years,
and number of relapses) and behavioral parameters, neuropsy-
chological scores and ERP measures.
Correlations between behavioral, neuropsychologicaļ and elec-
trophysiological measures were computed using Pearsons’s corre-
lation coefficient. The global reaction time and the global
percentage of correct responses were included as behavioral
measures (ANT) in the correlation matrix, whereas the number of
hits in the PASAT-3s, and the overall hit score in the SDMT, were
used as neuropsychological measures. For ERP data, 6 variables
were entered into the correlation analysis: the overall CNV, P1,
N1 and P3 amplitudes, and the overall P1 and N1 latencies.
For correlation analyses, a statistical-significance of p,0.001
was determined after Bonferroni adjustment, 0.05 significance
level divided by the total number (46) of multiple comparisons
tested.
Results
Demographic and clinical data
MS patients and controls did not differ in socio-demographic
variables. Both groups were equivalent with respect to sex, age,
handedness, and education level (p.0.05). The EDSS had a mean
value of 2.461.5. The mean year of the duration of the disease
was 7.1564.35 (see table 1).
Neuropsychological measures
About neuropsychological testing, the number of hits in the
PASAT-3s and the overall hit rate in the SDMT were registered
for all patients. Only the SDMT showed values of 2 SD under the
cut-off scores (considering the normative scores from Sepulcre et al
[35]), indicating an attentional impairment in our sample of
relapsing-remitting MS patients (SDMT score = 44613.82).
Lastly, BDI-II values indicated no severe signs of depression in
this sample of patients (BDI-II score = 7.4466.3) (see table 1).
Figure 2. 58 scalp electrodes recorded and sets of electrodes analyzed for each ERP (CNV, P1, N1 and P3) studied.
doi:10.1371/journal.pone.0097226.g002
Cognitive Impairment in Multiple Sclerosis
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e97226
Behavioral
Behavioral responses were slower in the patient group than the
controls under all conditions (F1, 50 = 26.64; p,0.001; g2 = 0.35)
(see table 2). After the general slowing had been removed in the
MS group to isolate the effects of each condition [40], a statistically
significant result was found for the interaction ‘‘Cue x Congruence
x Group’’ (F2, 100 = 6; p = 0.005; g2 = 0.1) (table 2 gives for mean
values under each condition). After post-hoc comparisons, all
corrected values for all conditions differed between the groups
except in No Cue-Congruent (p = 1.00) (see figure 1). Under some
conditions (Center Cue-Congruent, Spatial Cue-Congruent and
Spatial Cue-Incongruent), the difference was a lower corrected
value in the control subjects, which means a better relative
performance in this group for these conditions compared to
patients. In others (No Cue-Incongruent and Center Cue-
Incongruent), the patients had a lower value than the controls,
which means a better relative performance into this group than in
the control group for these conditions (note that a lower corrected
value after general slowing correction represents a shorter reaction
time than the average for each group). Regarding the accuracy of
the responses, MR-ANOVA showed no significant differences for
any of the main factors or their interactions between the 2 groups.
ERPs
Contingent Negative Variation. Controls and patients
showed the maximum amplitude value for the Contingent
Negative Variation (CNV) in the Cz and FcZ electrodes for all
cue conditions. Amplitude analysis of modulations in the CNV
related to the Cue Conditions showed no statistical difference
between groups in the No Cue Condition (F1, 50 = 1.89; p = 0.17;
g2 = 0.04) (Mean Control group: 21.69 mV60.47; Mean Patient
group: 20.99 mV60.22) (see figure 3). However, analysis of
modulations in the CNV related to the Central Cue condition
between groups showed a statistically significant difference for the
GROUP factor (F1, 50 = 6.1; p = 0.01; g2 = 0.11) (Mean Control
group: 23.38 mV61.05; Mean Patient group: 21.89 mV60.8).
Lastly, CNV amplitude in the Spatial Cue condition also showed a
statistically significant difference between the groups (F1,
50 = 4.58; p = 0.03; g2 = 0.08) (Mean Control group: 2
5.18 mV61.38; Mean Patient group: 23.51 mV60.8).
The target P1 and N1 components. Both groups showed
the maximum amplitude value for the P1 and N1 components in
the PO5 and PO6 electrodes for all cue x target conditions. Table 3
summarizes latency values of the P1 and N1 component analyzed
for each condition. MR-ANOVA showed a marginal effect in the
P1 latency by GROUP factor. (F1, 50 = 4.012; p = 0.05; g2 = 0.07)
(Mean Control group: 112 ms620; Mean Patient group: 121
ms623). With regard to the N1 component, MR-ANOVA
Table 1. Demographic, neuropsychological and clinical data of experimental subjects.
RRMS patients (n = 26) Healthy controls (n = 26)
Sex (m/f) 10/16 15/11
Age (years, mean±SD) 34.42 (6) 30.31 (9.3)
Handedness (left/right-handed) 1/25 1/25
Education (years, mean±SD) 17 (4.92) 18.58 (3.87)
Duration of disease (years, mean±SD) 7.15 (4.35) n.a
EDSS (mean, range) 2.4 (1–6) n.a
SDMT (mean±SD) 44 (13.82) n.a
PASAT-3s (mean±SD) 45.56 (14.34) n.a
BDI (II) (mean±SD) 7.44 (6.3) n.a
Key: RRMS: relapsing-remitting multiple sclerosis; m: male; f: female; EDSS: Expanded Disability Status Scale; SDMT: Symbol Digit Modality Test; PASAT-3s: Paced
Auditory Serial Addition Test-3 seconds; BDI (II): Beck Depression Inventory-II; SD: standard deviation.
doi:10.1371/journal.pone.0097226.t001
Table 2. ANT behavioral results.
Conditions Correction not applied Correction applied P-value (post-hoc)
RRMS (mean±SD) Controls (mean±SD) RRMS (mean±SD) Controls (mean±SD)
NC-C 592693 485669 0.9760.04 0.9760.04 1.000
NC-I 689678 580676 1.1460.05 1.1660.03 ,0.001
CC-C 561696 450673 0.9260.05 0.9060.04 ,0.001
CC-I 669678 562676 1.1060.03 1.1260.03 ,0.001
SC-C 516677 420662 0.85 60.03 0.8460.03 ,0.001
SC-I 623686 507666 1.0360.05 1.0160.04 ,0.001
Mean RT 607680 500668 n.a n.a ,0.001 (*)
* The p-value refers to the ‘‘Group’’ factor before correction for general slowing had been applied (see text for details). Abbreviations: RRMS: relapsing-remitting
multiple sclerosis; SD: standard deviation, RT: Reaction Time, NC-C: No cue congruent, NC-I: No cue incongruent, CC-C: Central cue congruent, CC-I: Central cue
incongruent, SC-C: Spatial cue congruent and SC-I: Spatial cue incongruent.
doi:10.1371/journal.pone.0097226.t002
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showed an effect in the N1 latency by GROUP factor (F1,
50 = 6.659; p = 0.01; g2 = 0.12) (Mean Control group: 176
ms616; Mean Patient group: 186ms623). No significant cue,
congruence or interactions of cue x congruence factors were found
in any of the 2 components. Regarding the amplitude, no
differences were found between groups (p.0.05) for the P1 and
N1 components in any condition.
The target P3 component. The maximum amplitude for the
P3 component in both groups was found in parietal regions (Pz) for
target conditions. There was a significant main effect for the
GROUP factor (F1, 50 = 10.526; p = 0.002; g2 = 0.14), which
indicates a decrease of the P3 amplitude in both conditions
(congruent and incongruent) for the MS group. No other
significant interactions were found (figure 4 and table 3).
Correlation analysis. EDSS, duration of disease in years
and number of relapses did not correlate significantly with any of
the behavioral, neuropsychological or ERP measures considered
in this study. PASAT-3s was negatively correlated (r: 20.624,
p = 0.001) with the Reaction Time (better performance in the
neuropsychological test, lower reaction time). There was a positive
correlation of accuracy of the responses with the SDMT (r: 0.654,
p,0.001) (a better accuracy in the behavioral responses, a better
score in the SDMT test). Lastly, the SDMT score and the overall
CNV amplitude were negatively correlated (r: 20.635, p = 0.001)
(better performance in the neuropsychological test, higher negative
amplitude value) (see figure 5). After Bonferroni correction for
multiple testing, no further significant correlations were detected
between the neuropsychological scores and the ERP parameters.
Discussion
A general slowing in reaction time for the RRMS group is seen
here, as in previous studies [41,42]. However, to isolate specific
effects on the attentional mechanisms, a correction suggested by
Fernández-Duque and Black [40] was applied. In particular, with
Figure 3. Contingent Negative Variation modulations at Cz electrode and topographic maps.
doi:10.1371/journal.pone.0097226.g003
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the corrected values, the No Cue-Congruent condition did not
differ between the 2 groups, but the No Cue-Incongruent
performance was relatively better in the patient group than the
controls. This result seems to demonstrate less interference
between alerting and executive network in the patient group than
the control group, probably because at some level the alerting
system is impaired. This supports previous studies that described
an alerting impairment and its interaction with the executive
network in MS patients [24,25,26]. However, this effect is not
strictly related to that considered by Fan et al. [13] In this case, we
refer to a tonic alerting effect that is present even in the absence of
a warning cue, i.e. the subject’s basic level of alertness during the
experimental session that is independent of the task. The CNV
amplitude found in the No cue condition for both groups supports
Table 3. Relevant results of latency and amplitude values found in this study.
RRMS patients (n = 26) Healthy controls (n = 26) P-value
CNV-NC amplitude (mean, SD) 20.99 mV60.22 21.69 mV60.47 p = 0.17
CNV-CC amplitude (mean, SD) 21.89 mV60.8 23.38 mV61.05 p = 0.01
CNV-SC amplitude (mean, SD) 23.51 mV60.8 25.18 mV61.38 p = 0.03
P1 latency (mean, SD) 121ms623 112ms620 p = 0.05
N1 latency (mean, SD) 186ms623 176ms616 p = 0.01
P3 amplitude (C+I) (mean, SD) 3.06 mV61.15 4.84 mV61.33 p = 0.002
Amplitude values shown for CNV and P3 represents the mean value of the electrodes analyzed in each component and condition studied. Latency values shown the
mean value at the peak of the six conditions analyzed for P1 and N1 components. Abbreviations: RRMS: relapsing-remitting multiple sclerosis; CNV: Contingent Negative
Variation, NC: No cue condition, CC: Central cue condition, SC: Spatial cue condition, C: Congruent condition, I: Incongruent condition, SD: Standard deviation, ms:
milliseconds and mV: microvolts.
doi:10.1371/journal.pone.0097226.t003
Figure 4. P3 component modulations at Pz electrode and topographic maps.
doi:10.1371/journal.pone.0097226.g004
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the idea that, even in here, this task elicits some level of alertness in
subjects (see figure 3). However, no statistical differences between
groups were found for this condition for the CNV. Therefore, no
clear neurophysiological index was identified that related to this
impairment of the tonic alerting effect, perhaps because it is a very
subtle brain activity.
For Central cue conditions, some kind of impairment is also
evident in the RRMS patients because no benefits accrued in the
Central Cue-Congruent condition and no cost was found in the
Central Cue-Incongruent condition. This suggests that a phasic
alerting initialized by the Central cue is not operating properly,
which could provoke impaired processing of upcoming stimuli.
Others have proposed that a general preparation of motor systems
occurs following a warning cue without spatial information, which
is related to the CNV [9,43,44,45]. Our data suggests that the
decreased amplitude of the CNV in the RRMS patients indicates
some impairment in the mechanisms in central cuing. This is the
first time that modulation of this component in RRMS patients
performing this paradigm has been described.
With regard to the orienting effect, the control group benefited
more than the patient group for both conditions (Spatial Cue-
Congruent and Spatial Cue-Incongruent). A similar result has
been described in MS patients using a different attentional task,
suggesting a compromised attentional mechanism in cue-orienta-
tion processes emerging in different stages of the disease [9], but
this is the first time it has been recorded in the ANT paradigm for
RRMS patients. A possible reason for the absence of orienting
impairment in previous behavioral studies using this paradigm
[24,25,26] is the difference in the SOA in the CNV interval.
Previous studies employed a SOA between the cue and target
onset of 400 ms, whereas ours was extended to 1150 ms to permit
better involvement of the orienting network for both experimental
groups. According to previous studies, CNV in spatial cuing is
related to the preparation of sensory and motor areas for the
subsequent stimulus [21,22,23]. Our data might be interpreted as
a lower preactivation in the patient group and hence a poorer
orienting behavioral response.
In the early event-related potentials, target P1 and N1
components showed delayed latency in all the conditions for the
MS group. This reflects specific impairment in the first steps of the
visual sensory processing, as noted in other studies as the result of
the demyelination process [8,46], and no atrophy as no
modulations were found for the amplitude in both components.
However, other studies have shown modulations in the amplitude
of early components that suggest possible heterogeneity in the
impairment provoked by this pathology [9,11].
Lastly, the P3 component showed a statistical significant
decrease in its amplitude for both congruent and incongruent
conditions in the RRMS group. Many hypotheses have been
posited to interpret decrements in the P3 amplitude. For instance,
Kratz et al. [19] mentioned that a lower amplitude for the P3
component in ADHD children showed less attentional resources
for this group. However, it is usually found in healthy subjects that
the P3 component is smaller in the incongruent P3 compared to
the congruent one when the Attention Network Test is used
[47,48]. A possible interpretation for this decrease is in fact the
other way round. The P3 component, built by several mechanisms
(evaluation of the stimuli, task relevancy, and so on) could show
dispersion on time of these mechanisms when the difficulty is
higher and more synchronization of these mechanisms when the
task demands are lower. In the first case, bigger attentional
demands lead to lower amplitude in the P3 and vice versa for the
congruent condition (less demanding). On this reasoning, smaller
P3 amplitude in the ADHD subjects could indeed reflect that these
patients are more challenged by the task that causes smaller P3
amplitude, with something similar occurring with our sample of
relapsing-remitting MS patients. We seem to find that the
attentional demand is higher for the patients in both conditions
(congruent and incongruent). However, it might be affirmed that
the executive function could to some degree be impaired in MS
patients as the incongruent condition shows less amplitude in this
group. However, more mechanisms must be impaired as
congruent condition shows a similar decrement. More research
Figure 5. Correlation analyses. Neuropsychological score (PASAT-
3s) and mean reaction time (upper panel); Accuracy in the Attention
Network Test and SDMT score (middle panel), and CNV amplitude and
SDMT score (lower panel).
doi:10.1371/journal.pone.0097226.g005
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is needed to clarify all the reasons for this behavior in the P3
component for MS patients.
In the correlation analysis, neither the EDSS nor the duration of
disease was strongly related to any of the behavioral and ERP
measures. For the EDSS, previous studies reported lower
correlations between EDSS and cognitive measures [49,50],
suggesting that the EDSS score (comprising diverse scores, not
exclusively cognitive) is not a good predictor of cognitive disability.
The duration of the disease has been related in previous studies to
the conflict effect [25]; but, as we have pointed out, network effects
(for instance, conflict or executive network as subtraction of
congruent versus incongruent) were not considered in our present
study as other authors recommend caution with these kind of
subtractions [16,17].
The neuropsychological measure, PASAT-3s, correlated in-
versely with reaction time, meaning that a better performance in
this neuropsychological test corresponds to a shorter reaction time.
Only SDMT correlated significantly with accuracy, better
performance in the SDMT, greater accuracy percentage for the
subject. All these correlations between neuropsychological mea-
sures and behavior suggest that this kind of test (ANT) could be
complementary in studying attentional impairment. Behavioral
measures are beneficial in computerized cognitive tests because of
their precision in the time-scale and the possibility of studying
specific mechanisms, which in the case of the neuropsychological
tests are all included. This makes it difficult to identify the specific
mechanism responsible for the attentional impairment [50], for
instance, PASAT-3s is sensitive to general slowing, sustained and
divided attention or working memory impairments.
The significant correlation between an ERP measure (CNV
amplitude) and the SDMT score shows that some mechanisms
involved in the performance of the neuropsychological testing are
represented in the CNV, as has been proposed elsewhere for other
ERP components (i.e. the P3 component) [11]. However, the lack
of other correlations with PASAT and SDMT and the rest of the
ERP components (P1, N1, etc.) indicate the difficulty of a simple
interpretation of these correlations between neuropsychology
scores and ERP measures. Further correlation analysis in cognitive
paradigms and with different ERP components are needed to
clarify this topic.
Conclusions
In summary, MS patients show multiple attentional impair-
ments. Both orienting and phasic alerting deficits seem to be
related to a decrease in CNV amplitude. In the case of the spatial
condition, this drop could be associated with a deficit in the
preactivation of the sensory and motor systems to process new
stimulus in new locations. In the case of the Central Cue
condition, the decreased amplitude of CNV could be related to
some impairment in the necessary mechanisms for a general
preactivation when a warning cue is presented. The delayed
latency for target P1 and N1 component shows that relapsing-
remitting MS patients are impaired in the first steps of the visual
sensory processing. Regarding the P3 component, reduced
amplitude for the incongruent in the patient group could represent
impairment for the executive network for these patients. However,
modulations in P3 may not exclusively be caused for this reason,
and other mechanisms could be involved. In the correlation
analysis, none of the behavioral measures were related to the
clinical variables, but all correlated strongly with the neuropsy-
chological tests (PASAT-3s and SDMT), and CNV also showed a
specifically high correlation with the SDMT. All these results
suggest that attentional impairment in MS patients is a complex
entity requiring multiple approaches for better assessment.
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Cognitive impairment in patients with multiple sclerosis using the Brief
Repeatable Battery-Neuropsychology test. Mult Scler 12(2): 187–195.
36. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression
Inventories -IA and –II in psychiatric outpatients. J Pers Assess 67(3): 588–597.
37. Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression
Inventory-II. San Antonio: Psychological Corporation.
38. Duncan CC, Barry RJ, Connolly JF, Fisher C, Michie PT, et al. (2009) Event-
related potentials in clinical research: guidelines for eliciting, recording, and
quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 120(11):
1883–1908.
39. Polich J (1986) P300 development from auditory stimuli. Psychophisiology 23(5):
590–597.
40. Fernández-Duque D, Black SE (2006) Attentional Networks in Normal Aging
and Alzheimer’s Disease. Neuropychology 20(2): 133–143.
41. Kail R (1998) Speed of information processing in patients with multiple sclerosis.
J Clin Exp Neuropsychol 20(1): 98–106.
42. De Sonneville LM, Boringa JB, Reuling IE, Lazeron RH, Adér HJ, et al. (2002)
Information processing characteristics in subtypes of multiple sclerosis.
Neuropychologia 40(11): 1751–1765.
43. VaezMousavi SM, Barry RJ (1993) Positive and negative shifts of the readiness
potential: preparatory effects. Int J Psychophysiol 15(2):105–113.
44. Baker KS, Mattingley JB, Chambers CD, Cunnington R (2011) Attention and
the readiness for action. Neuropsychologia 49(12): 3303–3313.
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